Skip to contentA
Astrana Health, Inc.
A
ASTHAstrana Health, Inc. Q1 2026 · 10-Q
Revenue$965.10M$965.10M+55.6% vs Q1 2025 Net Income$14.44M$14.44M+115.7% vs Q1 2025 EPS Diluted$0.29$0.29+107.1% vs Q1 2025 Operating Income$28,528,000+38.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Astrana Health, Inc. · CIK 1083446 · Engraved from SEC EDGAR
Free Cash Flowderived$64,056,000+372.5% Margins · derivedOperating margin3.0%−0.4 pt vs Q1 2025
Net margin1.5%+0.4 pt vs Q1 2025
ended Mar 31, 2026 · filed May 8, 2026 · 38 d after period end